← SynDRA
LEVOSIMENDAN
SynDRA canonical compound SYN0029468 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | TNNC1 |
| Mechanism of action | Calcium sensitizer |
| Indication | congestive heart failure |
| Disease area | cardiology |
All known targets
- TNNC1
- PDE3A
- KCNJ11
- KCNJ8
- PDE3B
- TNNI3
- TNNT2
Mechanisms of action (all sources)
- Calcium sensitizer
- PDE3A INHIBITOR
- Phosphodiesterase 3 inhibitor
- PDE3B INHIBITOR
- TNNC1 POSITIVE MODULATOR
- Troponin, cardiac muscle positive modulator
- TNNI3 POSITIVE MODULATOR
- TNNT2 POSITIVE MODULATOR
- TNNC1 STIMULATOR
- TNNC1 OPENER
Drug classes
- Cardiotonic Agents
- Cardiovascular Agents
- Enzyme Inhibitors
- Phosphodiesterase 3 Inhibitors
- Phosphodiesterase Inhibitors
- Protective Agents
- Vasodilator Agents
ATC classes
- C01C · CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Cross-references
Synonyms
- (R)-Simendan
- simdax
- (r)-simendan
- Simendan, (r)-
- (-)-OR-1259
- NSC-759644
- OR-1259
- OR1259
- Simdax
- Levosimedan
- Levosimendanum
- Levosimendan [INN]
- Simdax (TN)
- Levosimendan (USAN/INN)
- Mesoxalonitrile(p-((R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-pyridazinyl)phenyl)hydrazone
- Mesoxalonitrile (-)-(p((R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazone
- ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile
- (R)-((4-(1,4,5,6-Tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono) propanedintrile
- (R)-((4-(1,4,5,6-Tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile
- ({4-[(4R)-4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl]phenyl}hydrazono)propanedintrile
- 2-[[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]hydrazinylidene]propanedinitrile
- levosimendanum
- OR 1259
- NSC 759644
- CHEBI:50567
- C6T4514L4E
- DTXCID7026445
- RefChem:799036
- C01CX08
- MFCD00867135
- Simsndan;OR-1259
- SMR002529692
- CAS-141505-33-1
- Levosimendan [USAN:INN]
- UNII-C6T4514L4E
- Levosimendan (Standard)
- LEVOSIMENDAN [MI]
- LEVOSIMENDAN [USAN]
Look up LEVOSIMENDAN in the interactive SynDRA portal →